I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma
Study objective is to compare the efficacy and safety of camrelizumab in combination with adriamycin, cisplatin, ifosfamide and methotrexate in study population in China. Camrelizumab is a humanized anti-PD1 IgG4 monoclonal antibody.
resectable osteosarcoma
psychotropic
hepatitis c
adriamycin
camrelizumab
- 0 views
- 19 Feb, 2024
ABCB1/P-glycoprotein Expression Influence on Non-metastatic Osteosarcoma of the Extremities
As an adjuvant treatment, the following options may be given according to standard practice in each center: - If there is overexpression of ABCB1 / P-glycoprotein and poor response to induction treatment, in many sites ifosfamide at high doses and MTP-PE, is incorporated in addition to adriamycin. - If there …
adjuvant therapy
tumor necrosis
ejection fraction
p-glycoprotein
adriamycin
- 0 views
- 19 Feb, 2024